Direct Meds GLP-1 vs MEDVi: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Direct Meds GLP-1 beats MEDVi overall, scoring 7.9/10 vs 7.7/10. Direct Meds GLP-1 is more affordable at $297/mo vs $299/mo. Choose Direct Meds GLP-1 for users wanting simple, all-inclusive pricing without insuranc. Choose MEDVi for users who want a low entry price with oral and injectable co.
A side-by-side comparison of Direct Meds GLP-1 and MEDVi covering pricing, scores, medication types, insurance, and more to help you decide.
Direct Meds GLP-1
#13 of 40Straightforward compounded GLP-1 program with transparent all-inclusive pricing and no hidden fees.
Visit Direct Meds GLP-1MEDVi
#21 of 40Compounded GLP-1 platform offering both oral and injectable options with flexible dosing and affordable pricing.
Visit MEDVi| Feature | Direct Meds GLP-1 | MEDVi |
|---|---|---|
| Our Score | 7.9/10 | 7.7/10 |
| Starting Price | $297/mo | $299/mo |
| Medication Type | Compounded | Compounded |
| Insurance Accepted | No | No |
| Best For | Users wanting simple, all-inclusive pricing without insurance | Users who want a low entry price with oral and injectable compounded options |
| Ranking | #13 | #21 |
Pros & Cons Compared
Direct Meds GLP-1
Pros
- +True all-inclusive pricing — $280/mo covers medication, consultations, shipping, and pharmacy fees with no add-ons
- +Clear dose-based pricing published on their site — no surprise cost increases when titrating up
- +Fast pharmacy fulfillment: most orders ship within 48 hours of provider approval
- +Responsive customer support with live chat available during business hours
Cons
- −Compounded medications only — cannot prescribe brand-name Wegovy, Zepbound, or Ozempic
- −At $280/mo for compounded-only, it's pricier than competitors like Henry Meds ($199) or TrimRx ($179)
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179/mo is competitive for a platform with both oral and injectable compounded formulations
Cons
- −Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
Our Verdict
Direct Meds GLP-1 edges out MEDVi with a score of 7.9/10 vs 7.7/10. If budget is your priority, Direct Meds GLP-1 starts at $297/mo compared to MEDVi's $299/mo. Choose Direct Meds GLP-1 if you want: users wanting simple, all-inclusive pricing without insurance. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options.